Multicolor lineage tracing methods and intestinal tumors Hirotsugu YanaiToshihiro TanakaHiroo Ueno Review Open access 11 January 2013 Pages: 423 - 433
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease Yuki KawanoDavid E. Cohen Review Open access 09 February 2013 Pages: 434 - 441
Physiological roles of dietary glutamate signaling via gut–brain axis due to efficient digestion and absorption Kunio ToriiHisayuki UneyamaEiji Nakamura Review Open access 06 March 2013 Pages: 442 - 451
Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application Kazunari TominagaTetsuo Arakawa Review Open access 16 March 2013 Pages: 452 - 462
Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan Masatoshi NiigakiKyoichi AdachiYoshikazu Kinoshita Original Article—Alimentary Tract 14 September 2012 Pages: 463 - 472
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn Edoardo SavarinoPatrizia ZentilinVincenzo Savarino Original Article—Alimentary Tract 25 September 2012 Pages: 473 - 482
Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans Takeshi KannoKastunori IijimaTooru Shimosegawa Original Article—Alimentary Tract 03 October 2012 Pages: 483 - 490
Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis Yosui TamakiYukiomi NakadeMasashi Yoneda Original Article—Liver, Pancreas, and Biliary Tract 14 August 2012 Pages: 491 - 503
The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis Takao ItoiTerumi KamisawaTodd H. Baron Original Article—Liver, Pancreas, and Biliary Tract 06 September 2012 Pages: 504 - 514
Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus Toshihide ShimaHirofumi UtoTakeshi Okanoue Original Article—Liver, Pancreas, and Biliary Tract 22 August 2012 Pages: 515 - 525
Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C Reiichiro KondoHirohisa YanoMasayoshi Kage Original Article—Liver, Pancreas, and Biliary Tract 22 August 2012 Pages: 526 - 534
Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines Naoki HaradaNaoki HiramatsuTetsuo Takehara Original Article—Liver, Pancreas, and Biliary Tract 14 September 2012 Pages: 535 - 543
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer Stefan BoeckAndreas JungVolker Heinemann Rapid Communication 23 February 2013 Pages: 544 - 548
Body mass index and nonalcoholic fatty liver disease Shih-Wei LaiKuan-Fu Liao Letter to the Editor 17 January 2013 Pages: 549 - 549
Reply to the letter by Lai et al. regarding “Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal study” Teruki MiyakeTeru KumagiMorikazu Onji Letter to the Editor 30 January 2013 Pages: 550 - 551
Esophageal acid exposure still plays a major role in patients with NERD Edoardo SavarinoPatrizia ZentilinVincenzo Savarino Letter to the Editor 05 February 2013 Pages: 552 - 553
Answers to “The esophageal acid exposure still plays a major role in patients with NERD” by Dr. Savarino Liping Duan Letter to the Editor 05 February 2013 Pages: 554 - 554
Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for ‘middle’? Masaru EnomotoAkihiro TamoriNorifumi Kawada Letter to the Editor 13 February 2013 Pages: 555 - 556
Response to “Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for ‘middle’?” Kazuaki ChayamaC. Nelson HayesYoshiiku Kawakami Letter to the Editor 13 February 2013 Pages: 557 - 558